Consistent with our previous study (8), the plasma concentration of nesfatin-1 was also increased in the NAFLD rats, and significant correlations with the plasma levels of lipids, insulin, and leptin were observed. Here, NUCB2 is linked to metabolic dysfunction-associated steatotic liver disease.